Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors
Clinical trial NCT05522582 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05522582
- Sponsor
- Yancheng First People's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2023-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.